LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.00 | 21.74 | 6078 | 6081 | 0.9994 | 0.9999 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.00 | 21.74 | 10 | 6081 | 0.0016 | -0.0911 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.00 | 21.74 | 5756 | 6081 | 0.9465 | 0.9865 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.97 | 21.74 | 759 | 6084 | 0.1247 | 0.5482 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.97 | 21.74 | 6326 | 6084 | 1.0397 | 1.0096 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.97 | 21.74 | 14 | 6084 | 0.0023 | -0.0527 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.97 | 21.74 | 5957 | 6084 | 0.9791 | 0.9948 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.94 | 21.74 | 851 | 6121 | 0.1390 | 0.5694 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.94 | 21.74 | 6492 | 6121 | 1.0605 | 1.0145 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.94 | 21.74 | 16 | 6121 | 0.0026 | -0.0370 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.94 | 21.74 | 6084 | 6121 | 0.9938 | 0.9985 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.92 | 21.74 | 978 | 6070 | 0.1611 | 0.5975 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.92 | 21.74 | 6677 | 6070 | 1.1000 | 1.0236 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.92 | 21.74 | 16 | 6070 | 0.0026 | -0.0370 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 93.92 | 21.74 | 6341 | 6070 | 1.0446 | 1.0108 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.24 | 21.74 | 192 | 183 | 1.0459 | 1.0294 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.24 | 21.74 | 417 | 183 | 2.2716 | 1.6110 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.24 | 21.74 | 522 | 317 | 1.6426 | 1.2737 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.24 | 21.74 | 722 | 317 | 2.2720 | 1.4725 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.21 | 21.74 | 754 | 392 | 1.9235 | 1.3395 | MN20160310_N01 | E05 |